Digital inhalers may help predict the occurrence of acute exacerbations of chronic obstructive pulmonary disease (COPD) for ...

Home-based pulmonary rehabilitation has been slowly gaining momentum for chronic obstructive pulmonary disease (COPD), but access is still a challenge. "The science shows that there is greater ...

A recent study led by researchers at the Research Institute of the McGill University Health Centre (The Institute) underscores the critical role of assessing patients' peak inspiratory flow (PIF) when ...

Blood clots can form in both arteries and veins. However, the reasons behind them differ, as do the consequences and the chances of preventing blood clots. In Sweden, almost half of all cases of ...

The U.S. Food and Drug Administration has approved GSK's Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary ...

The FDA approved mepolizumab (Nucala) for adults with inadequately controlled chronic obstructive pulmonary disease (COPD), drugmaker GSK announced on Thursday. Labeling for the interleukin-5 (IL ...

A binomial regression analysis was performed to determine the sensitivity and specificity of the flow-volume curves, with obstruction confirmed by bronchoscopy being the dependent variable and each of ...

Investigators used 4D flow cardiovascular magnetic resonance imaging to search for differences between pulmonary artery (PA) remodeling in pulmonary arterial hypertension and other types of ...

New research reveals how COPD impacts women uniquely, urging tailored approaches for diagnosis and treatment.

The company analyzes urine samples using a lateral flow test and optical reader combined with artificial intelligence to predict lung disease exacerbations.

A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave the way for new treatment options.

The 2024 GOLD COPD Report includes updated research and recommendations that reflect shifts in thinking on COPD management.